Weekly HIV Pill Held Viral Suppression as Well as Daily Therapy in Phase 3 Trial

Once-weekly vs once-daily HIV treatment: What’s the difference?

This is how a promising once-weekly HIV treatment could revolutionise medication adherence for patients, offering a simpler alternative to daily regimens.

Weekly HIV Pill Held Viral Suppression as Well as Daily Therapy in Phase 3 Trial

A once-weekly HIV pill matched daily therapy for viral suppression in a phase 3 trial. It is not approved yet. Here is what the data show.

Once-weekly HIV pill performs as well as daily treatment

A once-weekly oral treatment for HIV is as effective as one of today’s leading daily therapies, offering the potential for a new treatment option that could reduce the burden of lifelong daily pill-taking.  This is according to the findings of a study that was published in the New England Journal of Medicine , and which come from the Phase 3 ISLEND-1 trial that evaluated a once-weekly tablet combining islatravir and lenacapavir in adults whose H…